This paper describes results from a systematic review and a series of meta-analyses of
nearly three decades worth of epidemiologic research on the relationship between non …

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive
diseases associated with poor outcome. Studies that focus specifically on PTCL are …

Background In 2015, the second cycle of the CONCORD programme established global
surveillance of cancer survival as a metric of the effectiveness of health systems and to …

Background Leukaemia is a heterogeneous group of haemopoietic cancers that comprises
a number of diverse and biologically distinct subgroups. We examine the leukaemia burden …

Changing definitions and classifications of hematologic malignancies (HMs) complicate
incidence comparisons. HAEMACARE classified HMs into groupings consistent with the …

The World Health Organization classification of non‐Hodgkin lymphoma (NHL) was
introduced in 2001. However, its incorporation into clinical practice is not well‐described …

In 2016 there were an estimated 7,460 newly diagnosed patients with marginal zone
lymphoma (MZL) in the US, which comprised 7% of all mature non-Hodgkin lymphomas …

There have been no prior large population-based studies focusing on cutaneous
lymphomas (CL) in the United States. Using the Surveillance, Epidemiology and End …

The incidence of a malignant disease reflects the genetic and cumulative exposure to the
environment of a population. Therefore, evaluation of the incidence and trends of a disease …

Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin
lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes …